Le Lézard
Classified in: Health
Subject: PLW

Redsense Receives Patent Approval in Sweden for its Smart Wound Care Technology for Optical Measuring of Blood and Exudate


STOCKHOLM, March 22, 2019 /PRNewswire/ -- Redsense Medical announces that the company will receive a patent approval in Sweden for the innovative smart wound care technology that was presented in November, 2018. The patent covers optical sensor measuring and will be valid until 2038.

Redsense has already received substantial interest in the technology from large international wound care companies. The company expects to have a functional prototype ready in Q2, 2019.

"This patent validates that we have created a unique solution that could contribute to improved global wound care. We are aiming to create a strong patent protection for the technology on all important regional markets, while continuing with our product development," says Redsense Medical's CEO Patrik Byhmer.

The company's smart wound care technology makes it possible to develop thin sensor layers for optical measuring of several physiological and biological parameters such as blood and exudate. The layer of sensors can be used separately or integrated directly into smart bandages or adhesive plasters. As the technology enables very cost and resource effective individual wound care, it has potential to revolutionize the global wound care market.

The global market for wound care products

The wound care market was valued at approximately USD 18 billion in 2016, and it is expected to grow at a CAGR of 5.3 % until 2023. The primary drivers of market growth are an ageing global population, a larger number of diabetics and increasing investments in research and development, which is also expected to lead to new research discoveries in this area. Chronic wounds are expected to constitute most of the wound care market up until 2022.

For more information, please contact
Patrik Byhmer,
CEO Redsense Medical AB (publ)
Telephone: +46(0)35 -10-60-30
Email: [email protected]
Website: www.redsensemedical.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/redsense/r/redsense-receives-patent-approval-in-sweden-for-its-smart-wound-care-technology-for-optical-measurin,c2769173

The following files are available for download:

https://mb.cision.com/Main/12367/2769173/1011815.pdf

PDF

SOURCE Redsense


These press releases may also interest you

19 avr 2024
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps. Designed to address...

19 avr 2024
Getting specialty medications into...

19 avr 2024
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

19 avr 2024
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

19 avr 2024
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

19 avr 2024
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...



News published on and distributed by: